全文获取类型
收费全文 | 43905篇 |
免费 | 242篇 |
国内免费 | 538篇 |
专业分类
系统科学 | 1210篇 |
丛书文集 | 75篇 |
教育与普及 | 277篇 |
理论与方法论 | 507篇 |
现状及发展 | 29055篇 |
研究方法 | 2篇 |
综合类 | 11372篇 |
自然研究 | 2187篇 |
出版年
2014年 | 392篇 |
2013年 | 799篇 |
2011年 | 2356篇 |
2009年 | 591篇 |
2008年 | 587篇 |
2007年 | 624篇 |
2006年 | 744篇 |
2005年 | 915篇 |
2004年 | 2040篇 |
2003年 | 1658篇 |
2002年 | 1304篇 |
2001年 | 887篇 |
2000年 | 418篇 |
1999年 | 671篇 |
1998年 | 638篇 |
1997年 | 770篇 |
1996年 | 527篇 |
1995年 | 394篇 |
1994年 | 678篇 |
1993年 | 687篇 |
1992年 | 641篇 |
1991年 | 578篇 |
1990年 | 633篇 |
1989年 | 465篇 |
1988年 | 446篇 |
1987年 | 440篇 |
1986年 | 539篇 |
1985年 | 640篇 |
1984年 | 610篇 |
1983年 | 528篇 |
1982年 | 704篇 |
1981年 | 751篇 |
1980年 | 811篇 |
1979年 | 1042篇 |
1978年 | 997篇 |
1977年 | 1005篇 |
1976年 | 909篇 |
1975年 | 870篇 |
1974年 | 595篇 |
1973年 | 937篇 |
1972年 | 1011篇 |
1971年 | 943篇 |
1970年 | 907篇 |
1969年 | 899篇 |
1968年 | 863篇 |
1967年 | 721篇 |
1966年 | 579篇 |
1965年 | 503篇 |
1964年 | 450篇 |
1963年 | 414篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
941.
The macromolecular peptide-loading complex in MHC class I-dependent antigen presentation 总被引:5,自引:1,他引:4
A challenging task for the adaptive immune system of vertebrates is to identify and eliminate intracellular antigens. Therefore
a highly specialized antigen presentation machinery has evolved to display fragments of newly synthesized proteins to effector
cells of the immune system at the cell surface. After proteasomal degradation of unwanted proteins or defective ribosome products,
resulting peptides are translocated into the endoplasmic reticulum by the transporter associated with antigen processing and
loaded onto major histocompatibility complex (MHC) class I molecules. Peptide-MHC I complexes are transported via the secretory
pathway to the cell surface where they are then inspected by cytotoxic T lymphocytes, which can trigger an immune response.
This review summarizes the current view of the intracellular machinery of antigen processing and of viral immune escape mechanisms
to circumvent destruction by the host.
Received 4 October 2005; received after revision 19 November 2005; accepted 24 November 2005 相似文献
942.
The mammalian olfactory system is not uniformly organized but consists of several subsystems each of which probably serves
distinct functions. Not only are the two major nasal chemosensory systems, the vomeronasal organ and the main olfactory epithelium,
structurally and functionally separate entities, but the latter is further subcompartimentalized into overlapping expression
zones and projection-related subzones. Moreover, the populations of ‘OR37’ neurons not only express a unique type of olfactory
receptors but also are segregated in a cluster-like manner and generally project to only one receptor-specific glomerulus.
The septal organ is an island of sensory epithelium on the nasal septum positioned at the nasoplatine duct; it is considered
as a ‘mini-nose’ with dual function. A specific chemosensory function of the most recently discovered subsystem, the so-called
Grueneberg ganglion, is based on the expression of olfactory marker protein and the axonal projections to defined glomeruli
within the olfactory bulb. This complexity of distinct olfactory subsystems may be one of the features determining the enormous
chemosensory capacity of the sense of smell. 相似文献
943.
Kertész A Váradi G Tóth GK Fajka-Boja R Monostori E Sármay G 《Cellular and molecular life sciences : CMLS》2006,63(22):2682-2693
Phosphopeptides interacting with src homology 2 (SH2) domains can activate essential signaling enzymes in vitro. When delivered to cells, they may disrupt protein-protein interactions, thereby influencing intracellular signaling. We
showed earlier that phosphopeptides corresponding to the inhibitory motif of Fcγ receptor IIb and a motif of the Grb2-associated
binder 1 adaptor protein activate SH2-containing tyrosine phosphatase 2 in vitro. To study the ex vivo effects of these peptides, we have now compared different methods for peptide delivery: (i) permeabilization of the target
cells and (ii) the use of cell-permeable vectors, which are potentially able to transport biologically active compounds into
B cells. We found octanoyl-Arg8 to be an optimal carrier for the delivery of phosphopeptides to the cells. With this strategy, the function of cell-permeable
SHP-2-binding phosphopeptides was analyzed. These peptides modulated the protein phosphorylation in B cells in a dose- and
time-dependent manner.
Received 27 July 2006; received after revision 4 September 2006; accepted 18 September 2006 相似文献
944.
Blasig IE Winkler L Lassowski B Mueller SL Zuleger N Krause E Krause G Gast K Kolbe M Piontek J 《Cellular and molecular life sciences : CMLS》2006,63(4):505-514
Tight junctions seal intercellular clefts via membrane-related strands, hence, maintaining important organ functions. We investigated
the self-association of strand-forming transmembrane tight junction proteins. The regulatory tight junction protein occludin
was differently tagged and cotransfected in eucaryotic cells. These occludins colocalized within the plasma membrane of the
same cell, coprecipitated and exhibited fluorescence resonance energy transfer. Differently tagged strand-forming claudin-5
also colocalized in the plasma membrane of the same cell and showed fluorescence resonance energy transfer. This demonstrates
self-association in intact cells both of occludin and claudin-5 in one plasma membrane. In search of dimerizing regions of
occludin, dimerization of its cytosolic C-terminal coiledcoil domain was identified. In claudin-5, the second extracellular
loop was detected as a dimer. Since the transmembrane junctional adhesion molecule also is known to dimerize, the assumption
that homodimerization of transmembrane tight junction proteins may serve as a common structural feature in tight junction
assembly is supported.
Received 6 October 2005; received after revision 14 December 2005; accepted 27 December 2005
†These authors contributed equally to this work. 相似文献
945.
Anti-amyloidogenic therapies: strategies for prevention and treatment of Alzheimer’s disease 总被引:1,自引:1,他引:0
Deposition of amyloid β-protein (Aβ) in the brain is an early and invariant neuropathological feature of Alzheimer’s disease
(AD). The current search for anti-AD drugs is mainly focused on modification of the process of accumulation of Aβ in the brain.
Here, we review four anti-amyloidogenic strategies: (i) reduction of Aβ production, which has mainly been approached with
secretase inhibition, (ii) promotion of the Aβ degrading catabolic pathway, including an Aβ degrading enzyme, neprilysin,
(iii) immunotherapy for Aβ and (iv) inhibition of Aβ aggregation. We have reported that AD patients have a favorable molecular
environment for Aβ aggregation and that various compounds, such as polyphenols, interfere with Aβ aggregation and destabilize
preformed Aβ fibrils.
Received 21 December 2005; received after revision 14 February 2006; accepted 29 March 2006 相似文献
946.
Huntington’s disease: from huntingtin function and dysfunction to therapeutic strategies 总被引:3,自引:0,他引:3
Borrell-Pagès M Zala D Humbert S Saudou F 《Cellular and molecular life sciences : CMLS》2006,63(22):2642-2660
Huntington’s disease (HD) is a neurodegenerative disorder that usually starts in middle age and is characterized by involuntary
movements (chorea), personality changes and dementia, leading to death within 10–20 years. The defective gene in HD contains
a trinucleotide CAG repeat expansion within its coding region that expresses a polyglutamine repeat in the protein huntingtin.
Together with the characteristic formation of aggregates in HD, aberrant protein interactions and several post-translational
modifications affect huntingtin during disease progression and lead to the dysfunction and death of selective neurons in the
brains of patients. The exact molecular mechanisms by which mutant huntingtin induces cell death are not completely understood
but may involve the gain of new toxic functions and the loss of the beneficial properties of huntingtin. This review focuses
on the cellular functions in which huntingtin is involved and how a better understanding of pathogenic pathways can lead to
new therapeutic approaches.
Received 24 May 2006; received after revision 5 July 2006; accepted 23 August 2006 相似文献
947.
The serine/threonine protein phosphatase 2A (PP2A) represents a large family of highly conserved heterotrimeric enzymes. Their
critical importance in cell homeostasis is underlined by the fact that they are targets of natural toxins like the tumor promoter
okadaic acid, and of simian virus 40 small tumor antigen (SV40 small t), a viral protein known to promote cell transformation.
Furthermore, mutated or lower expression levels of PP2A subunits have been found in certain cancers. One major known event
in PP2A-dependent cell transformation is the alteration of key signaling pathways that control cell growth and survival. In
this review, we focus on how PP2A enzymes also affect cell adhesion and cytoskeletal dynamics, the disruption of which is
linked to loss of cell polarity, increased cell motility and invasiveness. We also examine how those various pathways participate
in the transforming activity of SV40 small t.
Received 29 June 2006; received after revision 3 August 2006; accepted 20 September 2006 相似文献
948.
Human β-defensins 总被引:1,自引:0,他引:1
Pazgier M Hoover DM Yang D Lu W Lubkowski J 《Cellular and molecular life sciences : CMLS》2006,63(11):1294-1313
949.
Nodal signals pattern vertebrate embryos 总被引:4,自引:0,他引:4
Vertebrate embryonic patterning requires several conserved inductive signals–including Nodal, Bmp, Wnt and Fgf signals. Nodal,
which is a member of the transforming growth factor β (TGFβ) superfamily, activates a signal transduction pathway that is
similar to that of other TGFβ members. Nodal genes, which have been identified in numerous vertebrate species, are expressed
in specific cell types and tissues during embryonic development. Nodal signal transduction has been shown to play a pivotal
role in inducing and patterning mesoderm and endoderm, and in regulating neurogenesis and left-right axis asymmetry. Antagonists,
which act at different steps in the Nodal signal transduction pathway, have been shown to tightly modulate the inductive activity
of Nodal.
Received 20 October 2005; received after revision 15 November 2005; accepted 25 November 2005 相似文献
950.
Increasing evidence implies altered signaling through the neurotrophic receptor tyrosine kinase TrkB in promoting tumor formation
and metastasis. TrkB, sometimes in conjunction with its primary ligand BDNF, is often overexpressed in a variety of human
cancers, ranging from neuroblastomas to pancreatic ductal adenocarcinomas, in which it may allow tumor expansion and contribute
to resistance to anti-tumor agents. In vitro, TrkB acts as a potent suppressor of anoikis (detachment-induced apoptosis), which is associated with the acquisition of
an aggressive tumorigenic and metastatic phenotype in vivo. In view of its predicted contribution to tumorigenicity and metastasis in humans, TrkB corresponds to a potential drug target,
and preclinical models have already been established. The encouraging results of pharmacological Trk inhibitors in tumor xenograft
models suggest that TrkB inhibition may represent a promising novel anti-tumor therapeutic strategy. This hypothesis is currently
being evaluated in clinical trials. Here, we will discuss the latest developments on TrkB in these contexts as well as highlight
some critical questions that remain to be addressed for evaluating TrkB as a therapeutic target in cancer.
Received 12 October 2005; received after revision 19 December 2005; accepted 11 January 2006 相似文献